Cytodyn Inc (CYDY)

[Saltz]

Fred, If all goes well with FDA meeting the time to buy is now or prior to meeting.

Your scenario is the plan and it is dependent on:

Agreement by FDA to Lock and unblind study Oct. 12

Convincing PE and safety data PR first week in November

Organic rise in SP, and then hopefully a low ratio R/S to uplist to NASDAQ.

Then all eyes on BLA and Mono Trial.

IMO if this goes as planned buy out will happen before Mono P3 is completed because Pro-140 will be derisked to a palatable level for BP to move.

GVHD will be thrown in as an added bonus.

That is my understanding of managements plan.